Searching News Database: Targanta Therapeutics
HSMN NewsFeed - 20 May 2014
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 13 May 2009
The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor
The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor
HSMN NewsFeed - 26 Feb 2009
The Medicines Company Completes Acquisition of Targanta Therapeutics Corporation
The Medicines Company Completes Acquisition of Targanta Therapeutics Corporation
Additional items found! 4
Members Archive contains
4 additional stories matching:
Targanta Therapeutics
(Password required)
Targanta Therapeutics
(Password required)